Research in the Hodges lab focuses on altered epigenetic function in cancer and other diseases. We use interdisciplinary approaches, including epigenomics, live-cell super-resolution imaging, genome editing, and chemical biology, to understand epigenetic systems in disease settings. Our research is especially focused on new technologies, for example, improving cell-culture tumor models, as well as single-cell and single-molecule methods.
The epigenetic landscape is the bridge that connects the genome with its environment. We have taken a special interest in BAF (SWI/SNF) and PBAF ATP-dependent chromatin remodelers, which are among the most frequently mutated epigenetic regulators in cancer. We aim to improve precision therapies for tumors bearing these mutations by identifying how these complexes alter the intrinsic properties of cells and their interaction with the tumor microenvironment.
We are proud members of Baylor College of Medicine, Rice Department of Bioengineering, and the MD Anderson Center for Cancer Epigenetics.
We use new high-throughput approaches to reveal the epigenetic and metabolic mechanisms underlying human disease.
V Scholar Award from the V Foundation, 2018
Medical research award from Gabrielle's Angel Foundation for Cancer Research, 2018
$2M Faculty Recruitment Award from the Cancer Prevention and Research Institute of Texas, 2017
Pathway to Independence Award (K99/R00) from the National Cancer Institute, 2014 (renewed in 2017)